Ara
Toplam kayıt 5, listelenen: 1-5
The Effect of Systemic Chemotherapy on Ovarian Function: A Prospective Clinical Trial
(Aves, 2020)
Objective: Premenopausal women with breast cancer arc at risk of developing ovarian failure after chemotherapy. the aim of this study was to investigate the negative effects of systemic chemotherapy on ovarian function in ...
Identification of candidate biomarkers and pathways in breast cancer by differential network analysis
(Inderscience Enterprises Ltd, 2020)
Breast cancer is one of the most malignant cancers in women worldwide. The aim of the present study was to explore the underlying biological mechanisms of breast cancer. For this purpose, we propose a novel framework to ...
Evaluation of Abdominal Fat Ratio in Patients with Breast Cancer-Related Lymphedema: A Controlled Study
(Mary Ann Liebert, Inc, 2022)
Background: This study aimed to investigate the possible relationship between breast cancer-related lymphedema and central obesity, which is known to be effective in metabolic syndrome and chronic inflammation.Methods and ...
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
(Mdpi, 2023)
Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in pre-menopausal women. Studies have shown that AMH levels are more sensitive ...
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
(Dove Medical Press Ltd, 2023)
Background: The minichromosome maintenance protein-2 (MCM-2) is a more sensitive proliferation marker than Ki-67. This study aimed to evaluate the relationship between MCM-2 and Oncotype DX recurrence score (ODX-RS) and ...